InsidersTradesSigma
리메드: directors' dealings · South Korea · DART (FSS)
DART:company-cb6479KR·DART (FSS)Mcap 84.4Bn€Healthcare
Explore the full directors' dealings record of 리메드, a listed issuer based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 리메드 has published 2 insider filings. Market capitalisation: €84.4bn. The latest transaction was filed on 12 March 2026 — Other. Among the most active insiders: 이근용. The full history is free.
2
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
2730.00 €
Analyst consensus
Income statement
Revenue24.50 Bn€
Gross profit14.08 Bn€57% margin
Net income526.2 M€2.1% margin
Valuation
Beta0.70
Balance sheet & cash
Market cap84.38 Bn€
Total debt5.43 Bn€
Free Cash Flow1.53 Bn€
Debt / Equity13%
Profitability & ownership
ROE-0.1%
ROA0.8%
% insiders38.6%
% institutions0.0%
Last declaration on 12 March 2026